Yahoo · Nov 13, 2026
West Pharmaceutical Services (WST) Stock May Be 29% Overvalued On Cash Flow Views
West Pharmaceutical Services has been on a strong run, and the share price now puts a clear spotlight on one question: Are investors paying a level that its future cash flows can reasonably support, or has the market moved ahead of what the business is likely to generate in hard dollars over time? The stock has returned 54.7% over the past year, which puts real pressure on the cash flow outlook to justify how far the valuation has moved. The business model, built around drug delivery...


